Q1 2025 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2025-05-15 · accession 0000950123-25-005517
$413.7M
Reported value
7
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $223.8M | 54.1% | 10,935,310 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $57.1M | 13.8% | 5,462,846 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $43.2M | 10.4% | 9,632,561 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $38.1M | 9.21% | 3,909,696 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $29.3M | 7.08% | 3,452,330 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $20.4M | 4.93% | 3,822,537 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $1.7M | 0.42% | 2,878,148 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.